BIOMAT Database Logo BIOMAT Database Logo

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1. 2008

Angeline P C Lim, and Steven K K Wong, and Annie H Y Chan, and Conrad E Z Chan, and Eng Eong Ooi, and Brendon J Hanson
Defence Medical and Environmental Research Institute, DSO National Laboratories, 27 Medical Dr, 117510, Singapore. lpeichie@dso.org.sg

The monoclonal antibody VN04-2 was previously shown to protect mice against lethal A/Vietnam/1203/04 H5N1 virus challenge when administered pre- and post-infection. In this study, we characterized the binding requirements of this antibody using direct binding to hemagglutinin and neutralization assays with H5N1 virus-like particles (H5N1-VLP) of eight recent H5N1 strains representing the major mutations within the 140s antigenic loop. Binding was clade independent and 3 mutations within this antigenic region are required before escape is possible, suggesting that apart from the H5N1 viruses circulating in Indonesia, VN04-2 may provide protection against H5N1 viruses from all other regions.

UI MeSH Term Description Entries
D007214 Indonesia A republic stretching from the Indian Ocean east to New Guinea, comprising six main islands: Java, Sumatra, Bali, Kalimantan (the Indonesian portion of the island of Borneo), Sulawesi (formerly known as the Celebes) and Irian Jaya (the western part of New Guinea). Its capital is Djakarta. The ethnic groups living there are largely Chinese, Arab, Eurasian, Indian, and Pakistani; 85% of the peoples are of the Islamic faith. Celebes,Indonesian New Guinea,Irian Jaya,Java,Madoera,Netherlands East Indies,New Guinea, Indonesian,New Guinea, West,Sulawesi,Sumatra,Timor,West Irian,Bali,East Indies,Madura,Malay Archipelago
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D014771 Virion The infective system of a virus, composed of the viral genome, a protein core, and a protein coat called a capsid, which may be naked or enclosed in a lipoprotein envelope called the peplos. Virus Particle,Viral Particle,Viral Particles,Particle, Viral,Particle, Virus,Particles, Viral,Particles, Virus,Virions,Virus Particles

Related Publications

Angeline P C Lim, and Steven K K Wong, and Annie H Y Chan, and Conrad E Z Chan, and Eng Eong Ooi, and Brendon J Hanson
Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants.
January 2022, Viruses,
Angeline P C Lim, and Steven K K Wong, and Annie H Y Chan, and Conrad E Z Chan, and Eng Eong Ooi, and Brendon J Hanson
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.
March 2006, Hepatology (Baltimore, Md.),
Angeline P C Lim, and Steven K K Wong, and Annie H Y Chan, and Conrad E Z Chan, and Eng Eong Ooi, and Brendon J Hanson
Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodies.
November 2012, Journal of virology,
Angeline P C Lim, and Steven K K Wong, and Annie H Y Chan, and Conrad E Z Chan, and Eng Eong Ooi, and Brendon J Hanson
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses.
April 2022, Current opinion in virology,
Angeline P C Lim, and Steven K K Wong, and Annie H Y Chan, and Conrad E Z Chan, and Eng Eong Ooi, and Brendon J Hanson
A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.
March 2012, Journal of virology,
Angeline P C Lim, and Steven K K Wong, and Annie H Y Chan, and Conrad E Z Chan, and Eng Eong Ooi, and Brendon J Hanson
Characterization of human single-chain antibodies against highly pathogenic avian influenza H5N1 viruses: mimotope and neutralizing activity.
October 2010, Journal of biochemistry,
Angeline P C Lim, and Steven K K Wong, and Annie H Y Chan, and Conrad E Z Chan, and Eng Eong Ooi, and Brendon J Hanson
A broadly neutralizing human monoclonal antibody is effective against H7N9.
September 2015, Proceedings of the National Academy of Sciences of the United States of America,
Angeline P C Lim, and Steven K K Wong, and Annie H Y Chan, and Conrad E Z Chan, and Eng Eong Ooi, and Brendon J Hanson
Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin.
February 2013, Journal of virology,
Angeline P C Lim, and Steven K K Wong, and Annie H Y Chan, and Conrad E Z Chan, and Eng Eong Ooi, and Brendon J Hanson
Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
February 2012, Biochemical and biophysical research communications,
Angeline P C Lim, and Steven K K Wong, and Annie H Y Chan, and Conrad E Z Chan, and Eng Eong Ooi, and Brendon J Hanson
Epitope mapping and characterization of a neutralizing monoclonal antibody against human adenovirus type 3.
November 2013, Virus research,
Copied contents to your clipboard!